Integrated Filing — IndAS



General information about company
Scrip Code 500459
NSE Symbol PGHH
MSEI Symbol NOTLISTED
ISIN INE179A01014
Name of company Procter & Gamble Hygiene and Health Care Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Jul-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 27-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-Mar-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Hygiene and Health Care
Start date and time of board meeting 27-May-2025   17:17:00
End date and time of board meeting 27-May-2025   17:47:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-08-23
Indicate Company website link for updated RPT policy of the Company https://in.pg.com/india-governance-and-policies/pghh/terms-and-policies/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Jul-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 9916300000 33744200000
Other income 191300000 373400000
Total income 10107600000 34117600000
2 Expenses
(a) Cost of materials consumed 1754000000 5672200000
(b) Purchases of stock-in-trade 2100300000 6728900000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 93000000 150000000
(d) Employee benefit expense 493700000 1760500000
(e) Finance costs 57700000 143000000
(f) Depreciation, depletion and amortisation expense 103500000 319400000
(f) Other Expenses
1 Advertising & sales promotion expenses 1211600000 4524400000
2 Other expenses 2167200000 6197600000
Total other expenses 3378800000 10722000000
Total expenses 7981000000 25496000000
3 Total profit before exceptional items and tax 2126600000 8621600000
4 Exceptional items 0 0
5 Total profit before tax 2126600000 8621600000
6 Tax expense
7 Current tax 568000000 2307500000
8 Deferred tax -2400000 -51800000
9 Total tax expenses 565600000 2255700000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 1561000000 6365900000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 1561000000 6365900000
17 Other comprehensive income net of taxes -19300000 -70600000
18 Total Comprehensive Income for the period 1541700000 6295300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 324600000 324600000
Face value of equity share capital 3246 3246
27 Details of debt securities
22 Reserves excluding revaluation reserve 7045300000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 48.09 196.11
Diluted earnings (loss) per share from continuing operations 48.09 196.11
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 48.09 196.11
Diluted earnings (loss) per share from continuing and discontinued operations 48.09 196.11
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) 1)The above audited financial results for the quarter and nine month period ended March 31, 2025, have been reviewed and recommended by the Audit Committee and approved by the Board of Directors nof the Company at their respective meetings held on May 27, 2025. These financial results have been subjected to an audit by the statutory auditors of the Company, who have expressed an unmodified nopinion thereon. These financial results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. n2)These Financial Results are prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards (Ind AS), as amended, prescribed under Section 133 of nthe Companies Act 2013, read with relevant Rules issued thereunder and other accounting principles generally accepted in India. n3)The Board of Directors of the Company, on January 23, 2025, approved the change of the Financial Year end from June 30th to March 31st. Accordingly, the current Financial Year of the Company viz., n2024-25 shall be for a period of nine months commencing on July 1, 2024, and ending on March 31, 2025. Due to this change of period, the figures of the current period are not comparable with those of nthe previous year. n4)The Board of Directors at its meeting held on May 27, 2025, have recommended a payment of final dividend of Rs. 65 per equity share of face value Rs.10 each aggregating to Rs. 21 099 lakhs. n5)During the previous year, the Company had arrived at an Advanced Pricing Agreement with the concerned tax authorities, determining appropriate transfer pricing methodology for certain identified ntransactions with the Company’s affiliate(s) for the years ended March 2011 to March 2019. As a consequence of this agreement, an additional tax liability, amounting to Rs. 1656 lakhs, and interest namounting to Rs. 1944 lakhs, had been accounted as Prior Period Tax Adjustments and Finance Costs respectively in the previous year. n6)During the previous year, certain Property, Plant & Equipment of the Company having a written down value of Rs. 2,282 lakhs as at June 30, 2024, which were licensed to a contract manufacturer whose narrangement was terminated in F.Y. 2022-23, had been tested for impairment and an impairment loss amounting to Rs. 1,303 lakhs had been recognized in the financial results for the year ended June 30, n2024. During the current period, the Company has reassessed the impairment recognised based on an “Agreement to Sell” entered into with a buyer and has reversed the excess provision for impairment nloss of Rs. 673 lakhs under “Other Income”. The Company has now recorded these items of Property, Plant & Equipment amounting to Rs. 1,619 lakhs as Non Current Assets held for sale. n7)The Company's operating segments under Ind AS 108 – Operating Segments are as follows: n - Health Care Products – Comprising of Ointment and Creams, Cough Drops and Tablets. n - Hygiene Products - Comprising of Feminine Hygiene products and other skin care hygiene. nThese individual operating segments have been aggregated into a single primary reportable segment i.e. manufacturing, trading and marketing of Health and Hygiene Products in accordance with Ind AS n108-Operating Segments. Accordingly, no separate segment information has been provided. n8)The Company does not have a subsidiary, associate or a joint venture as at March 31, 2025. n9)The figures for the last quarter ended March 31, 2025, are the balancing figures between the audited figures in respect of the nine month period ended March 31, 2025 and the published unaudited year to ndate figures upto the end of the second quarter ended December 31, 2024. n nFor 3 months ended March 31,2025: nCurrent tax includes prior year adjustments of Rs. 513 lakhs. nFor the year ended March 31,2025 nCurrent tax includes prior year adjustments of Rs. 939 lakhs nDeferred tax includes prior year adjustments of Rs. -269 lakhs n nIn the cash flow statement: nOther inflows/outflows of cash include changes in earmarked balances and bank deposits forming part of investing activities. nOther inflows/outflows of cash includes Inventory written off (net of Insurance claims recovered) and Provisions no longer required written back forming part of operating activities.



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Jul-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1313700000
Capital work-in-progress 407100000
Investment property
Goodwill 0
Other intangible assets 0
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 0
Trade receivables, non-current
Loans, non-current 386200000
Other non-current financial assets 43400000
Total non-current financial assets 429600000
Deferred tax assets (net) 824200000
Other non-current assets 3504500000
Total non-current assets 6479100000
2 Current assets
Inventories 2214000000
Current financial asset
Current investments 0
Trade receivables, current 3041000000
Cash and cash equivalents 4663700000
Bank balance other than cash and cash equivalents 143300000
Loans, current 46300000
Other current financial assets 351300000
Total current financial assets 8245600000
Current tax assets (net)
Other current assets 446700000
Total current assets 10906300000
3 Non-current assets classified as held for sale 161900000
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 17547300000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 324600000
Other equity 7045300000
Total equity attributable to owners of parent 7369900000
Non controlling interest
Total equity 7369900000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 100000
Total non-current financial liabilities 100000
Provisions, non-current 1166700000
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 1166800000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 75400000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 8018800000
Total Trade payable 8094200000
Other current financial liabilities 216000000
Total current financial liabilities 8310200000
Other current liabilities 570700000
Provisions, current 129700000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 9010600000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 10177400000
Total equity and liabilites 17547300000
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block
Textual Information(1) Other non-current assets includes non-current tax assets of Rs. 23043 nother non-current financial liabilities includes lease liabilities nother current financial liabilities includes lease liabilities.



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Jul-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Jul-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re- measurement of defined benefit plans -25800000 -94300000
Total Amount of items that will not be reclassified to profit and loss -25800000 -94300000
2 Income tax relating to items that will not be reclassified to profit or loss -6500000 -23700000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -19300000 -70600000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jul-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 8621600000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 141400000
Adjustments for decrease (increase) in inventories -58100000
Adjustments for decrease (increase) in trade receivables, current -656600000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 72900000
Adjustments for decrease (increase) in other non-current assets -34100000
Adjustments for other financial assets, non-current -19500000
Adjustments for other financial assets, current 536600000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -423600000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 319400000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 24200000
Adjustments for provisions, non-current -13600000
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 277600000
Adjustments for share-based payments 61200000
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -327400000
Net cash flows from (used in) operations 8294200000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 2430600000
Other inflows (outflows) of cash 68500000
Net cash flows from (used in) operating activities 5932100000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 4100000
Purchase of property, plant and equipment 550300000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 243500000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -40100000
Net cash flows from (used in) investing activities -342800000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 7800000
Dividends paid 6654500000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -6662300000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -1073000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -1073000000
Cash and cash equivalents cash flow statement at beginning of period 5736700000
Cash and cash equivalents cash flow statement at end of period 4663700000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Kalyaniwalla & Mistry LLP Yes 30-Jul-2027


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE INDIA LIMITED Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 7519000 1871000 4802000
2 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HAIR CARE, LLC Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 194000 582000 0
3 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HEALTH LIMITED Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 14842000 12547000 11844000
4 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 24610000 63688000 7323000
5 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA SINGAPORE BRANCH Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 115000 419000 112000
6 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE PHILIPPINES, INC. Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 855000 0 837000
7 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE GILLETTE COMPANY LLC Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 508000 0 501000
8 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE COMPANY Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 10523000 61912000 10091000
9 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE U.S. BUSINESS SERVICES COMPANY Group Company Any other transaction Affiliate reimbursements- payments 4190000000 Approved 8421000 1358000 4433000
10 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE INDIA LIMITED Group Company Any other transaction Domestic cost sharing 4190000000 Approved 519000 26478000 0
11 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Domestic cost sharing 4190000000 Approved 131446000 94378000 8159000
12 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE MANUFACTURING GMBH Group Company Any other transaction Import of spares 4190000000 Approved 5460000 0 2996000
13 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE DIVERSIFIED OPERATIONS PVT LTD Group Company Any other transaction Processing charges 4190000000 Approved 610047000 425632000 325384000
14 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE DIVERSIFIED OPERATIONS PVT LTD Group Company Any other transaction Rent 4190000000 Approved 3154000 0 962000
15 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Rent 4190000000 Approved 17738000 0 4589000
16 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE COMPANY Parent Company Any other transaction Royalty 4190000000 Approved 462185000 525295000 392857000
17 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Purchase of fixed assets 4190000000 Approved 944000 0 0
18 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE DISTRIBUTING LLC Group Company Purchase of fixed assets 4190000000 Approved 15199000 0 6083000
19 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Purchase of goods or services 4190000000 Approved 1782598000 0 0
20 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Purchase of raw materials 4190000000 Approved 7675000 0 0
21 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA Group Company Purchase of goods or services 4190000000 Approved 29394000 0 5641000
22 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE PHILIPPINES BUSINESS SERVICES, INC. Group Company Purchase of goods or services 4190000000 Approved 42386000 0 17688000
23 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE COMPANY Group Company Purchase of goods or services 4190000000 Approved 255525000 0 63733000
24 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE U.S. BUSINESS SERVICES COMPANY Group Company Purchase of goods or services 4190000000 Approved 29430000 0 8204000
25 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE DIVERSIFIED OPERATIONS PVT LTD Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 27151000 4513000 11278000
26 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE INDIA LIMITED Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 8944000 8517000 1938000
27 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HAIR CARE, LLC Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 2476000 0 0
28 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HEALTH LIMITED Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 39951000 14029000 13508000
29 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 36158000 11784000 12343000
30 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 3112000 3235000 3112000
31 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA SINGAPORE BRANCH Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 6548000 46446000 6547000
32 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE MANUFACTURING (THAILAND) LTD. Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 228000 152000 228000
33 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PT PROCTER & GAMBLE HOME PRODUCTS INDONESIA Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 220000 1385000 220000
34 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED TAMBRANDS INC. Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 343000 114000 228000
35 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE GILLETTE COMPANY LLC Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 175000 0 175000
36 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE COMPANY Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 81797000 2536000 76688000
37 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE MANUFACTURING COMPANY Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 167000 0 0
38 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE PAPER PRODUCTS COMPANY Group Company Any other transaction Affiliate reimbursements- receipts 4190000000 Approved 93000 0 62000
39 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE INDIA LIMITED Group Company Any other transaction Domestic cost sharing 4190000000 Approved 55853000 17451000 22531000
40 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Domestic cost sharing 4190000000 Approved 118211000 74765000 46642000
41 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HOME PRODUCTS PRIVATE LIMITED Group Company Any other transaction Sale of raw materials 4190000000 Approved 15742000 0 0
42 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED GILLETTE DIVERSIFIED OPERATIONS PVT LTD Group Company Sale of goods or services 4190000000 Approved 839000 0 0
43 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE BANGLADESH PRIVATE LIMITED Group Company Sale of goods or services 4190000000 Approved 24635000 0 73497000
44 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE HEALTH LIMITED Group Company Sale of goods or services 4190000000 Approved -3276000 0 0
45 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA Group Company Sale of goods or services 4190000000 Approved 193457000 0 0
46 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA SINGAPORE BRANCH Group Company Sale of goods or services 4190000000 Approved 61677000 0 0
47 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED PROCTER & GAMBLE INTERNATIONAL OPERATIONS, S.A. Group Company Sale of goods or services 4190000000 Approved 41547000 0 4914000
48 PROCTER & GAMBLE HYGIENE & HEALTH CARE LIMITED THE PROCTER & GAMBLE DISTRIBUTING LLC Group Company Sale of goods or services 4190000000 Approved 33015000 0 7029000
Total value of transaction during the reporting period 4210350000